Upcoming events

Switch to Calendar View

• New Paradigms in Cardiology: Managing Obesity and Cardiovascular Disease in Cardiology Practice

  • When
    16 Jul 2025
  •  
    7:00 PM
  • Location
    Virtual

  New Paradigms in Cardiology: Managing Obesity and Cardiovascular Disease in Cardiology Practice

  with Pam R. Taub, MD, FACC, FASPC

  Director of Preventive Cardiology

  Director of Step Family Foundation Cardiovascular

  Rehabilitation and Wellness Center

  Professor of Medicine - UC San Diego Health System

  La Jolla, California

  
  

  Cardiovascular disease (CVD) is one of the leading causes of death worldwide. Recognizing that obesity is a major and consistent risk factor for CVD, the burden of CVD is expected to rise along with the obesity rate. Early intervention is central to reducing the risk of obesity-related comorbidities, including CVD, but a significant proportion of individuals with obesity are never diagnosed and do not receive specialty care. Modest weight reduction improves health outcomes, with significant weight loss resulting in even greater health benefits. Consistent with this, guidelines for obesity management advocate the use of multiple interventions to address weight management. How can cardiology teams do their part?

  Cardiologists are increasingly involved in this new era where obesity and cardiovascular (CV) comorbidities can be treated in tandem.

  This live, regional educational series allows learners to interact with an expert and ask their questions about a topic that seems to be everywhere. By the end, learners will better understand when and how to prioritize the treatment of obesity and how anti-obesity medications affect weight and CV risk. Taking that knowledge one step further, the expert will share practical strategies to effectively diagnose and treat patients in the cardiology setting. Stay ahead of the curve in these paradigm-shifting times for CVD.

  Don’t miss your chance to participate!

  Educational Objectives

  Upon completion of this activity, participants should be better able to:

  • Explain the rationale for prioritizing the treatment of obesity in the context of mitigating CV risk among patients with excess weight
  • Describe the long-term efficacy and safety of weight loss pharmacotherapy to reduce the risk of obesity-related CV comorbidities
  • Apply diagnostic and monitoring strategies that facilitate evidence-based interventions to manage excess body weight or obesity in cardiology care settings

  Accreditation, Support, and Credit

  In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

  Support

  This activity is supported by an educational grant from Novo Nordisk Inc.

  Physicians

  PVI, PeerView Institute for Medical Education, designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity

  
  

  
  

  Show details
• ACC Legislative Conference

  • Start
    5 Oct 2025
  • End
    7 Oct 2025
  • Location
    Washington, D.C.

  
  

  Show details
• 2025 ACC-Mass Annual Meeting

  • When
    25 Oct 2025
  • Location
    AC Hotel, 125 Front St. Worcester, MA 01608

  
  

  Show details